Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Not applicableStudy completedNCT02924922
What this trial is testing

Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy

Who this might be right for
Kidney Neoplasms
Luzerner Kantonsspital 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT03308396
What this trial is testing

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

Who this might be right for
Advanced Kidney CancerKidney CancerClear Cell Renal Cell Carcinoma
Ajjai Alva, MD 57
Not applicableStudy completedNCT07406646
What this trial is testing

Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)

Who this might be right for
Renal Cell CarcinomaAdvanced Kidney Cancer
Institute of Oncology Ljubljana 91
Early research (Phase 1)Study completedNCT05293496
What this trial is testing

MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCastration-Resistant Prostatic CancerMalignant Melanoma+4 more
MacroGenics 31
Not applicableUnknownNCT02207686
What this trial is testing

Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?

Who this might be right for
Von Hippel-Lindaus Disease
Marie Luise Bisgaard, MD 50
Not applicableUnknownNCT06583369
What this trial is testing

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

Who this might be right for
Hand-Foot Syndrome
Peking University Cancer Hospital & Institute 220
Testing effectiveness (Phase 2)UnknownNCT04146831
What this trial is testing

Sintilimab in FH-deficient Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaFH-deficientSintilimab
West China Hospital 37
Testing effectiveness (Phase 2)Study completedNCT02599324
What this trial is testing

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Urothelial CarcinomaAdvanced Gastric Adenocarcinoma+1 more
Pharmacyclics LLC. 263
Testing effectiveness (Phase 2)Active Not RecruitingNCT03401788
What this trial is testing

Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

Who this might be right for
VHL - Von Hippel-Lindau SyndromeVHL Gene MutationVHL Syndrome+3 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 50
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT03097328
What this trial is testing

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bradley A. McGregor, MD 39
Early research (Phase 1)Study completedNCT00422344
What this trial is testing

RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06284564
What this trial is testing

A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

Who this might be right for
Metastatic Renal Cell Carcinoma
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03115801
What this trial is testing

A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Urothelial Carcinoma
Weill Medical College of Cornell University 6
Testing effectiveness (Phase 2)UnknownNCT05578664
What this trial is testing

Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer

Who this might be right for
Oligometastatic Renal Cell Carcinoma
Consorzio Oncotech 81
Not applicableStudy completedNCT01026337
What this trial is testing

Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer
Abramson Cancer Center at Penn Medicine 43
Testing effectiveness (Phase 2)Study completedNCT01178411
What this trial is testing

An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) Protocols

Who this might be right for
Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Not applicableActive Not RecruitingNCT05782400
What this trial is testing

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Testing effectiveness (Phase 2)Study completedNCT00731211
What this trial is testing

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 57
Next Page